Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?
Hasan Çilgin Medicine Faculty, Obstetrics and Gynecology Department, Kafkas University, Kars, Turkey Purpose: This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline.Materials and method...
Main Author: | Çilgin H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/can-a-cyclooxygenase-inhibitor-be-an-option-for-treatment-of-ovarian-h-peer-reviewed-article-DDDT |
Similar Items
-
Diosmin versus cabergoline for prevention of ovarian hyperstimulation syndrome
by: Ahmed Samy Saad, et al.
Published: (2017-09-01) -
The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
by: Marzieh Agha Hosseini, et al.
Published: (2011-09-01) -
Large-volume paracentesis, up to 27 L, with adjuvant vaginal cabergoline in the case of severe ovarian hyperstimulation syndrome with successful pregnancy outcome: A case report
by: Nupur Agarwal, et al.
Published: (2017-01-01) -
Cabergoline versus Coasting in the Prevention of Ovarian Hyperstimulation Syndrome and Assisted Reproductive Technologies Outcome in High Risk Patients
by: Farnaz Sohrabvand, et al.
Published: (2009-05-01) -
Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
by: Nikita Naredi, et al.
Published: (2013-01-01)